JP2005053841A - Skin care preparation for external use - Google Patents

Skin care preparation for external use Download PDF

Info

Publication number
JP2005053841A
JP2005053841A JP2003286619A JP2003286619A JP2005053841A JP 2005053841 A JP2005053841 A JP 2005053841A JP 2003286619 A JP2003286619 A JP 2003286619A JP 2003286619 A JP2003286619 A JP 2003286619A JP 2005053841 A JP2005053841 A JP 2005053841A
Authority
JP
Japan
Prior art keywords
starch
skin
acid
external preparation
trehalose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003286619A
Other languages
Japanese (ja)
Inventor
Hiromi Wada
洋巳 和田
Kenji Onaka
憲治 大仲
Kazuyuki Ikeyama
和幸 池山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KYOUTO BIOMEDICAL SCIENCE KK
Original Assignee
KYOUTO BIOMEDICAL SCIENCE KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KYOUTO BIOMEDICAL SCIENCE KK filed Critical KYOUTO BIOMEDICAL SCIENCE KK
Priority to JP2003286619A priority Critical patent/JP2005053841A/en
Publication of JP2005053841A publication Critical patent/JP2005053841A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a skin care preparation for external use such as a skin lotion giving the skin humectancy and sustaining the humectant feeling. <P>SOLUTION: This skin care preparation for external use contains trehalose and starch compound(s) and also an electrolyte. The skin care preparation is in the form of an aqueous solution. In this skin care preparation for external use, the contents of the trehalose and the starch compound(s) are 0.1-10 wt.% and 0.01-10 wt.%, respectively, and the starch compound(s) are selected from red bean starch, corn starch, wheat starch, rice starch, potato starch, hydroxyethyl starch, hydroxypropyl starch, dextrin, α-cyclodextrin, β-cyclodextrin and γ-cyclodextrin. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

この発明は、皮膚外用剤に属し、特に皮膚の乾燥を防止する皮膚外用剤に関する。   The present invention belongs to an external preparation for skin, and particularly relates to an external preparation for skin that prevents drying of the skin.

皮膚は生体面の表面にあって直接外界に接しているため、絶えずいろいろな刺激を受けている。このような刺激によって、角質層の水分保持機能、また生体内部の水分が失われないようにする水分バリアー機能が低下すると、乾燥肌に陥る。従来より、皮膚の乾燥を防ぎ、細胞を保護するために、トレハロース、ヒアルロン酸ナトリウム、ブチレングリコール等の保湿成分を含有する皮膚外用剤が種々検討されてきた。
特開2000−34216
Since the skin is on the surface of the living body and is in direct contact with the outside world, it constantly receives various stimuli. When the moisture retention function of the stratum corneum and the moisture barrier function that prevents the loss of moisture inside the living body are reduced by such stimulation, the skin falls into dry skin. Conventionally, various skin external preparations containing a moisturizing component such as trehalose, sodium hyaluronate, butylene glycol have been studied in order to prevent skin dryness and protect cells.
JP 2000-34216 A

しかし、従来の皮膚外用剤は保湿効果は得られるものの、その保湿感を持続させるという機能が十分でなかった。
それ故、この発明の課題は、皮膚に保湿性を与えるとともに、その保湿感を持続させうる皮膚外用剤を提供することである。
However, although the conventional skin external preparation has a moisturizing effect, the function of maintaining the moisturizing feeling has not been sufficient.
Therefore, an object of the present invention is to provide an external preparation for skin that can impart moisture retention to the skin and maintain the moisture retention.

上記課題を解決するために、この発明の皮膚外用剤は、トレハロース及びデンプン類を含むことを特徴とする。
この発明の皮膚外用剤によれば、トレハロースが皮膚に保湿性を与え、デンプン類がその保湿感を持続させるバリアー機能を有する。その結果、皮膚外用剤がトレハロース及びデンプン類を有効量含む水溶液からなる場合、使用時にべたつかず、保湿性に優れ、その保湿感を持続させることができる。
In order to solve the above-mentioned problems, the external preparation for skin of the present invention is characterized by containing trehalose and starches.
According to the external preparation for skin of the present invention, trehalose imparts moisture retention to the skin, and starches have a barrier function that maintains the moisturizing feeling. As a result, when the external preparation for skin is composed of an aqueous solution containing an effective amount of trehalose and starch, it is not sticky during use, has excellent moisturizing properties, and can maintain its moisturizing feeling.

トレハロースとデンプン類を含有させることで、皮膚に保湿性を示すとともに、保湿感を持続させる皮膚外用剤を得ることができる。   By containing trehalose and starches, it is possible to obtain an external preparation for skin that exhibits moisturizing properties to the skin and maintains the moisturizing feeling.

本発明皮膚外用剤の実施形態としては、化粧水、ローション、エッセンス、ジェル、乳液、クリーム、パック・マスクなど様々な化粧品が考えられる。さらには噴霧器に封入してスプレーとして使用することも可能である。また剤形は液剤、錠剤、ゲル剤、粉剤を問わない。
デンプン類とは、α−グルコースの重合体である下記の化学式で表されるデンプン、デンプンの分子内の水素原子の1個又は2個以上がそれぞれ独立に他の基で置換されたデンプン誘導体、ならびにデキストリンやシクロデキストリン等のデンプンの部分加水分解物を総称するものである。この発明で用いるデンプン類は、このように定義される化合物であって、当該皮膚外用剤における他の成分と配合して皮膚に適用したときに、この発明の課題を解決する効果を発揮するものである限り、その化学構造、性状、純度、調整方法は特定のものに限定されない。
As an embodiment of the skin external preparation of the present invention, various cosmetics such as lotion, lotion, essence, gel, milky lotion, cream, pack and mask can be considered. Furthermore, it can be enclosed in a nebulizer and used as a spray. The dosage form may be liquid, tablet, gel or powder.
Starch is a starch represented by the following chemical formula, which is a polymer of α-glucose, a starch derivative in which one or more hydrogen atoms in the starch molecule are each independently substituted with another group, In addition, it is a general term for partial hydrolysates of starch such as dextrin and cyclodextrin. The starches used in the present invention are compounds defined in this way, and exhibit the effect of solving the problems of the present invention when blended with other components in the skin external preparation and applied to the skin. As long as the chemical structure, properties, purity, and adjustment method are not limited to specific ones.

Figure 2005053841
Figure 2005053841

上記デンプン誘導体としては、上記の化学式で表されるデンプンにおける水素原子の1個又は2個以上がそれぞれ独立に、例えばメチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、ビニル基、アリル基などの脂肪族炭化水素基で置換されたものが挙げられる。またデンプンの加水分解物としては、デキストリン、好ましくはα-シクロデキストリン、β-シクロデキストリン、γ-シクロデキストリンが挙げられる。
この発明の皮膚外用剤は、通常水溶液の形態にあって、その全量に対するトレハロース及びデンプン類の含有量がトレハロース0.1〜10重量%、デンプン類0.01〜10重量%であり、望ましくはトレハロース0.5〜4%、デンプン類0.1〜4%である。トレハロースが10重量%を超えるとべたつきやすく、デンプン類が10重量%を超えると水溶液となりにくいからである。
この発明の皮膚外用剤には電解質を含有させることもできる。電解質としては、塩酸、リン酸、炭酸、硫酸などの無機酸のアルカリ金属またはアルカリ土類金属の塩、及びクエン酸、リンゴ酸、コハク酸、グルコン酸、乳酸などの有機酸のアルカリ金属またはアルカリ土類金属の塩から選ばれる1種又は2種以上が挙げられる。例えば塩化ナトリウム、塩化カリウム、リン酸ニ水素カリウム、リン酸水素二カリウム、リン酸カルシウム、炭酸マグネシウム、硫酸カルシウム、クエン酸ナトリウム、リンゴ酸ナトリウム、グルコン酸ナトリウム、グルコン酸カリウム、乳酸ナトリウムである。
この発明の皮膚外用剤には、さらに必要に応じて、植物抽出エキス、水溶性高分子、酸化防止剤、紫外線吸収剤など一般に化粧品に配合される成分を含有させることができ、一層付加価値を高めた皮膚外用剤を製造することができる。
As the starch derivative, one or more of hydrogen atoms in the starch represented by the above chemical formula are each independently, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, vinyl group. And those substituted with an aliphatic hydrocarbon group such as an allyl group. Examples of the hydrolyzate of starch include dextrin, preferably α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin.
The external preparation for skin of the present invention is usually in the form of an aqueous solution, and the trehalose and starch content relative to the total amount is 0.1-10 wt% trehalose, 0.01-10 wt% starch, Trehalose is 0.5 to 4% and starches are 0.1 to 4%. This is because if trehalose exceeds 10% by weight, it tends to be sticky, and if the starch exceeds 10% by weight, it is difficult to form an aqueous solution.
The skin external preparation of this invention can also contain an electrolyte. Examples of the electrolyte include alkali metal or alkaline earth metal salts of inorganic acids such as hydrochloric acid, phosphoric acid, carbonic acid, and sulfuric acid, and alkali metals or alkalis of organic acids such as citric acid, malic acid, succinic acid, gluconic acid, and lactic acid. One type or two or more types selected from earth metal salts may be mentioned. For example, sodium chloride, potassium chloride, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, calcium phosphate, magnesium carbonate, calcium sulfate, sodium citrate, sodium malate, sodium gluconate, potassium gluconate, sodium lactate.
The external preparation for skin of the present invention can further contain components that are generally blended in cosmetics such as plant extract, water-soluble polymer, antioxidant, UV absorber, etc. An enhanced skin external preparation can be produced.

この発明でいう植物抽出エキスとしては、ラズベリーエキス、明日葉エキス、ローズマリーエキス、うこんエキス、イチョウ葉エキス、ジュウヤクエキス、シソエキス、アロエエキス、緑茶エキス、ヨモギエキス、ラベンダーエキス、桑白皮エキス、ハトムギエキス、柚子エキス、ユキノシタエキス、カンゾウ(甘草)エキス、アルゲエキス、カッコンエキス、セイヨウハッカエキス、ベニバナエキス、ヘチマエキスなどが挙げられる。
この発明でいう水溶性高分子としては、ペクチン、アガロース、ジェランガム、キサンタンガム、キトサン、コラーゲン、マリンコラーゲン、フィブロイン、セリシン、アラビアガム、カラギーナン、アルギン酸、ヒアルロン酸、コンドロイチン硫酸、ヘパリン、デルマンダン硫酸、ヘパラン硫酸、ケラタン硫酸、カルボキシビニルポリマー、カルボキシメチルセルロース、メチルセルロースなどが挙げられる。
The plant extract referred to in the present invention includes raspberry extract, tomorrow leaf extract, rosemary extract, ukon extract, ginkgo biloba extract, jujube extract, perilla extract, aloe extract, green tea extract, mugwort extract, lavender extract, mulberry bark extract, Examples include barley extract, coconut extract, cypress extract, licorice (licorice) extract, algae extract, cuckoo extract, mint extract, safflower extract, loofah extract and the like.
Examples of the water-soluble polymer in the present invention include pectin, agarose, gellan gum, xanthan gum, chitosan, collagen, marine collagen, fibroin, sericin, gum arabic, carrageenan, alginic acid, hyaluronic acid, chondroitin sulfate, heparin, dermandan sulfate, heparan sulfate. , Keratan sulfate, carboxyvinyl polymer, carboxymethylcellulose, methylcellulose and the like.

この発明でいう酸化防止剤としては、アスコルビン酸、トコフェノール、ジブチルヒドロキシトルエン、酢酸トコフェノールなどが挙げられる。助剤としては、リン酸、クエン酸、アスコルビン酸、マレイン酸、マロン酸、コハク酸、フマル酸、ケファリン、ヘキサメタフォスフェイト、フィチン酸、EDTAなどが挙げられる。
この発明でいう紫外線吸収剤としては、オキシベンゾンなどのベンゾフェノン誘導体、パラメトキシケイ皮酸2エチルヘキシルなどのメトキシケイ皮酸誘導体、サリチル酸2エチルヘキシルなどのサリチル酸誘導体などが挙げられる。
以下、この発明を実施例に基づいて具体的に説明する。
Examples of the antioxidant referred to in the present invention include ascorbic acid, tocophenol, dibutylhydroxytoluene, and tocophenol acetate. Examples of the auxiliary agent include phosphoric acid, citric acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumaric acid, kephalin, hexametaphosphate, phytic acid, EDTA, and the like.
Examples of the ultraviolet absorber used in the present invention include benzophenone derivatives such as oxybenzone, methoxycinnamic acid derivatives such as 2-methoxyhexyl paramethoxycinnamate, and salicylic acid derivatives such as 2-ethylhexyl salicylate.
Hereinafter, the present invention will be specifically described based on examples.

重量基準で以下の成分を含有し、残部が精製水である比較例1〜2、実施例1〜3及び対照の皮膚外用剤を調合した。
比較例1:トレハロース2%、グルコン酸ナトリウム1%、リン酸水素二カリウム0.15%、リン酸二水素カリウム0.05%
比較例2:デキストリン1.5%、グルコン酸ナトリウム1%、リン酸水素二カリウム0.15%、リン酸二水素カリウム0.05%
実施例1:トレハロース2%、デキストリン1.5%、グルコン酸ナトリウム1%、リン酸水素二カリウム0.15%、リン酸二水素カリウム0.05%
実施例2:トレハロース10%、デキストリン3%、グルコン酸ナトリウム2%、リン酸水素二カリウム0.3%、リン酸二水素カリウム0.09%
実施例3:トレハロース2%、デキストリン1.5%、グルコン酸ナトリウム1%、リン酸水素二カリウム0.15%、リン酸二水素カリウム0.05%、柚子エキス2%、エタノール4%、グリセリン2%
対照:グルコン酸ナトリウム2%、リン酸水素二カリウム0.3%、リン酸二水素カリウム0.09%
Comparative Examples 1-2, Examples 1-3, and a control external preparation for skin containing the following components on a weight basis and the balance being purified water were prepared.
Comparative Example 1: Trehalose 2%, sodium gluconate 1%, dipotassium hydrogen phosphate 0.15%, potassium dihydrogen phosphate 0.05%
Comparative Example 2: Dextrin 1.5%, sodium gluconate 1%, dipotassium hydrogen phosphate 0.15%, potassium dihydrogen phosphate 0.05%
Example 1: Trehalose 2%, dextrin 1.5%, sodium gluconate 1%, dipotassium hydrogen phosphate 0.15%, potassium dihydrogen phosphate 0.05%
Example 2: Trehalose 10%, dextrin 3%, sodium gluconate 2%, dipotassium hydrogen phosphate 0.3%, potassium dihydrogen phosphate 0.09%
Example 3: Trehalose 2%, dextrin 1.5%, sodium gluconate 1%, dipotassium hydrogen phosphate 0.15%, potassium dihydrogen phosphate 0.05%, eggplant extract 2%, ethanol 4%, glycerin 2%
Controls: sodium gluconate 2%, dipotassium hydrogen phosphate 0.3%, potassium dihydrogen phosphate 0.09%

化粧品使用経験のあり、皮膚疾患のない健康な女性10名(22〜58歳)を被験者とし、対照、比較例1〜2及び実施例1〜3の皮膚外用剤について使用試験を行った。被験者に上記の組成に関して情報を一切与えずに、左腕に対照、右腕に比較例1〜2及び実施例1〜3の皮膚外用剤のいずれか一つを無作為に選択して塗布してもらい、3日後に左腕に再び対照、右腕に残りの未使用の比較例及び実施例のいずれか一つを塗布してもらうという操作を繰り返し、13日間に亘って行った。塗布後、使用感、保湿感、皮膜感、保湿持続感の4つ項目について、対照と比較して、「-2:対照よりかなり劣る」、「-1:対照より劣る」、「0:対照と同等」、「+1:対照より優れている」、「+2:対照よりかなり優れている」の5段階で被験者に評価させた。評価結果を表1に示す。なお表中の数字は各評価を下した被験者の人数を表わす。   Ten healthy women (22-58 years old) who have cosmetic use experience and have no skin diseases were subjects, and the use test was conducted on the skin preparations for control, Comparative Examples 1-2 and Examples 1-3. Without giving any information on the above-mentioned composition to the subject, randomly select and apply one of the skin external preparations of Comparative Examples 1-2 and Examples 1-3 to the left arm and the right arm. Three days later, the control was again applied to the left arm and the remaining one of the remaining comparative examples and examples was applied to the right arm, and the operation was repeated for 13 days. After application, the four items of feeling of use, moisturizing feeling, film feeling, and moisturizing feeling are compared with the control: “-2: considerably inferior to the control”, “-1: inferior to the control”, “0: control” Equivalent ”,“ +1: better than control ”, and“ +2: much better than control ”. The evaluation results are shown in Table 1. The numbers in the table represent the number of subjects who made each evaluation.

評価項目のうち、保湿感は字義通りであり、使用感はべとつきの無い(ある)場合を優れて(劣って)いるとし、皮膜感は膜の存在が感じられる(感じられない)場合を優れて(劣って)いるとし、保湿維持感は12時間後の保湿感と定義する。   Among the evaluation items, the moisturizing feeling is literally, the feeling of use is excellent (inferior) when there is no stickiness (existing), and the feeling of film is excellent when the presence of the film is felt (not felt) The moisturizing feeling is defined as the moisturizing feeling after 12 hours.

Figure 2005053841
Figure 2005053841

表1に見られるように、保湿感においては、トレハロースを含まない比較例2では対照とほぼ同等であるが、それ以外の例においては、対照よりも優れているという評価が得られた。このことより、トレハロースには保湿作用があることを示している。
皮膜感においては、デキストリンを含まない比較例1では対照と同等であるが、それ以外の例では、対照より優れているという評価が得られた。このことから、デキストリンには皮膜作用があることを示している。
保湿維持感において、トレハロースを含むがデキストリンを含まない比較例1に比べて、トレハロース及びデキストリンの両方を含む実施例1〜3がいずれも保湿維持感が優れていることから、トレハロースによって与えられた保湿感は、デキストリンの皮膜作用によって維持されることを示している。
ところで、使用感においては、実施例2だけが対照より劣っていた。しかし、実施例1及び3のようにトレハロースとデキストリンの濃度を下げることによって改善された。このことから、両成分を適切な濃度で配合することで皮膚外用剤に適した使用感を与えられることがわかる。
As can be seen from Table 1, in the moisturizing feeling, Comparative Example 2 containing no trehalose was almost equivalent to the control, but in other examples, the evaluation was superior to the control. This indicates that trehalose has a moisturizing action.
In the film feeling, Comparative Example 1 containing no dextrin was equivalent to the control, but the other examples were evaluated to be superior to the control. This indicates that dextrin has a film action.
In the moisturizing and maintaining feeling, compared to Comparative Example 1 containing trehalose but not containing dextrin, Examples 1 to 3 containing both trehalose and dextrin were all given excellent feeling of moisturizing and thus were given by trehalose. The moisturizing feeling is maintained by the film action of dextrin.
By the way, in the feeling of use, only Example 2 was inferior to the control. However, it was improved by lowering the concentration of trehalose and dextrin as in Examples 1 and 3. From this, it can be seen that blending both components at appropriate concentrations can provide a feeling of use suitable for an external preparation for skin.

Claims (6)

トレハロース及びデンプン類を含むことを特徴とする皮膚外用剤。   An external preparation for skin comprising trehalose and starches. トレハロースの含有量が0.1〜10重量%、デンプン類の含有量が0.01〜10重量%であり、水溶液からなる請求項1に記載の皮膚外用剤。   The skin external preparation according to claim 1, comprising trehalose in an amount of 0.1 to 10% by weight, starches in an amount of 0.01 to 10% by weight, and comprising an aqueous solution. デンプン類がアズキデンプン、トウモロコシデンプン、コムギデンプン、コメデンプン、バレイショデンプン、ヒドロキシエチルスターチ、ヒドロキシプロピルデンプン、デキストリン、α-シクロデキストリン、β-シクロデキストリン及びγ-シクロデキストリンから選ばれる1種又は2種以上である請求項1に記載の皮膚外用剤。   One or two starches selected from azuki starch, corn starch, wheat starch, rice starch, potato starch, hydroxyethyl starch, hydroxypropyl starch, dextrin, α-cyclodextrin, β-cyclodextrin and γ-cyclodextrin It is the above, The skin external preparation of Claim 1. 電解質をさらに含む請求項1〜3のいずれかに記載の皮膚外用剤。   The external preparation for skin according to any one of claims 1 to 3, further comprising an electrolyte. 電解質が塩酸、リン酸、炭酸、硫酸などの無機酸のアルカリ金属またはアルカリ土類金属の塩、及びクエン酸、リンゴ酸、コハク酸、グルコン酸、乳酸などの有機酸のアルカリ金属またはアルカリ土類金属の塩から選ばれる1種又は2種以上である請求項4に記載の皮膚外用剤。   The electrolyte is an alkali metal or alkaline earth metal salt of an inorganic acid such as hydrochloric acid, phosphoric acid, carbonic acid or sulfuric acid, and an alkali metal or alkaline earth of an organic acid such as citric acid, malic acid, succinic acid, gluconic acid or lactic acid. The external preparation for skin according to claim 4, which is one or more selected from metal salts. 植物エキスをさらに含む請求項1〜4のいずれかに記載の皮膚外用剤。   The skin external preparation in any one of Claims 1-4 which further contain a plant extract.
JP2003286619A 2003-08-05 2003-08-05 Skin care preparation for external use Pending JP2005053841A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003286619A JP2005053841A (en) 2003-08-05 2003-08-05 Skin care preparation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003286619A JP2005053841A (en) 2003-08-05 2003-08-05 Skin care preparation for external use

Publications (1)

Publication Number Publication Date
JP2005053841A true JP2005053841A (en) 2005-03-03

Family

ID=34365861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003286619A Pending JP2005053841A (en) 2003-08-05 2003-08-05 Skin care preparation for external use

Country Status (1)

Country Link
JP (1) JP2005053841A (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011502125A (en) * 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー A new class of treatments that promote small molecule diffusion
JP2014037363A (en) * 2012-08-15 2014-02-27 Neoinvent Co Ltd Aqueous composition for moisture retention
US8901174B2 (en) 2007-04-13 2014-12-02 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
US9604899B2 (en) 2002-02-25 2017-03-28 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US9950067B2 (en) 2005-02-24 2018-04-24 Diffusion Pharmaceuticals, LLC Trans carotenoids, their synthesis, formulation and uses
US10130689B2 (en) 2009-06-22 2018-11-20 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
EP3307283A4 (en) * 2015-06-10 2018-12-26 Cellphire Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
KR20190077823A (en) * 2017-12-26 2019-07-04 조현주 Pack composition comprising red bean
CN113599292A (en) * 2021-08-13 2021-11-05 上海应用技术大学 Preparation method of micromolecular oligosaccharide moisturizing gel
US11185523B2 (en) 2016-03-24 2021-11-30 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US11529587B2 (en) 2019-05-03 2022-12-20 Cellphire, Inc. Materials and methods for producing blood products
US11701388B2 (en) 2019-08-16 2023-07-18 Cellphire, Inc. Thrombosomes as an antiplatelet agent reversal agent
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
US11903971B2 (en) 2020-02-04 2024-02-20 Cellphire, Inc. Treatment of von Willebrand disease

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (en) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk Percutaneous absorption type preparation containing dihydroetorphine
JPH11217313A (en) * 1997-11-27 1999-08-10 Shiseido Co Ltd Pack cosmetic
JP2000319187A (en) * 1999-05-06 2000-11-21 Medion Research Laboratories Inc Carbon dioxide transcutaneous and transmucosal absorption composition
JP2002370918A (en) * 2001-06-14 2002-12-24 Tokiwa Corp Non-emulsified and powder dispersed-in-oil type cosmetic
WO2003101460A1 (en) * 2002-06-03 2003-12-11 Cac Corporation External preparations for treating dermatitis
JP2005289815A (en) * 2002-04-16 2005-10-20 Cac:Kk External preparation for enhancing cell activity

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (en) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk Percutaneous absorption type preparation containing dihydroetorphine
JPH11217313A (en) * 1997-11-27 1999-08-10 Shiseido Co Ltd Pack cosmetic
JP2000319187A (en) * 1999-05-06 2000-11-21 Medion Research Laboratories Inc Carbon dioxide transcutaneous and transmucosal absorption composition
JP2002370918A (en) * 2001-06-14 2002-12-24 Tokiwa Corp Non-emulsified and powder dispersed-in-oil type cosmetic
JP2005289815A (en) * 2002-04-16 2005-10-20 Cac:Kk External preparation for enhancing cell activity
WO2003101460A1 (en) * 2002-06-03 2003-12-11 Cac Corporation External preparations for treating dermatitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAEST G: "Starch. The natural choice.", SOAP PERFUM COSMET, vol. 71/8, JPN6010003987, August 2001 (2001-08-01), GB, pages 39 - 40, ISSN: 0001524928 *

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9604899B2 (en) 2002-02-25 2017-03-28 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US11278621B2 (en) 2005-02-24 2022-03-22 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
US9950067B2 (en) 2005-02-24 2018-04-24 Diffusion Pharmaceuticals, LLC Trans carotenoids, their synthesis, formulation and uses
US8901174B2 (en) 2007-04-13 2014-12-02 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
JP2011502125A (en) * 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー A new class of treatments that promote small molecule diffusion
US10130689B2 (en) 2009-06-22 2018-11-20 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
US11147859B2 (en) 2009-06-22 2021-10-19 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
US11491129B2 (en) 2010-06-02 2022-11-08 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
US10016384B2 (en) 2010-06-02 2018-07-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
JP2014037363A (en) * 2012-08-15 2014-02-27 Neoinvent Co Ltd Aqueous composition for moisture retention
EP3307283A4 (en) * 2015-06-10 2018-12-26 Cellphire Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
US11185523B2 (en) 2016-03-24 2021-11-30 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
KR102055940B1 (en) * 2017-12-26 2019-12-13 조현주 Pack composition comprising red bean
KR20190077823A (en) * 2017-12-26 2019-07-04 조현주 Pack composition comprising red bean
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
US11529587B2 (en) 2019-05-03 2022-12-20 Cellphire, Inc. Materials and methods for producing blood products
US11752468B2 (en) 2019-05-03 2023-09-12 Cellphire, Inc. Materials and methods for producing blood products
US11813572B2 (en) 2019-05-03 2023-11-14 Cellphire, Inc. Materials and methods for producing blood products
US11701388B2 (en) 2019-08-16 2023-07-18 Cellphire, Inc. Thrombosomes as an antiplatelet agent reversal agent
US11903971B2 (en) 2020-02-04 2024-02-20 Cellphire, Inc. Treatment of von Willebrand disease
CN113599292A (en) * 2021-08-13 2021-11-05 上海应用技术大学 Preparation method of micromolecular oligosaccharide moisturizing gel

Similar Documents

Publication Publication Date Title
JP2005053841A (en) Skin care preparation for external use
TWI392515B (en) Skin topical composition
US5977188A (en) Humectant and an endermic liniment
JP5989226B2 (en) Gel-like composition for skin
EP2618810B1 (en) Cosmetic composition
JPH09221410A (en) Aging preventing skin ointment
US20110311470A1 (en) Compositions for a powder having an aqueous phase
KR20070079367A (en) Wrinkle treatment cosmetic composition with fructose 1,6-diphosphate trisodium salt
JP2009286723A (en) Aqueous gel-like cosmetic
JP6673935B2 (en) Composition for scalp, cosmetic for scalp and method of applying composition for scalp
JP2008094799A (en) Sulfated glycosaminoglycan production promoter and external preparation for skin containing the same
EP3967372A1 (en) Gel-type external composition for skin
JP2002275027A (en) Cosmetic and cosmetic impregnated in nonwoven fabric
JP2005336116A (en) Skin cosmetic
JP6284437B2 (en) Body odor suppressor
KR102223208B1 (en) Cosmetic composition for anti-wrinkles and preventing white cast
JP2019011301A (en) Oral composition
JP6895584B2 (en) Powder-containing body odor suppressant
JP6925929B2 (en) Oral composition
JP7118931B2 (en) oral composition
JP5303225B2 (en) Gray hair improver
JP2019011300A (en) Oral composition
JP5137326B2 (en) Topical skin preparation
JP2004307489A (en) Antipruritic composition for external application
JP4541728B2 (en) Topical skin preparation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100608